Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Jensen

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cancer Research|March 27, 1998
Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol)B H Long, J M Carboni, A J Wasserman, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|May 22, 2013
In vivo and in vitro liver cancer metabolism observed with hyperpolarized [5-(13)C]glutamineC Cabella, M Karlsson, C Canapè, et al.
Biophysical Chemistry|June 1, 1995
Energy, control and DNA structure in the living cellJ E Wijker, P R Jensen, J L Snoep, et al.
Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cancer Research|March 27, 1998
Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol)B H Long, J M Carboni, A J Wasserman, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|May 22, 2013
In vivo and in vitro liver cancer metabolism observed with hyperpolarized [5-(13)C]glutamineC Cabella, M Karlsson, C Canapè, et al.
Biophysical Chemistry|June 1, 1995
Energy, control and DNA structure in the living cellJ E Wijker, P R Jensen, J L Snoep, et al.
Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.
Pageof 6